Status:

COMPLETED

Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

Lead Sponsor:

Allergan

Conditions:

Migraine Disorders

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

This study will evaluate the efficacy, safety and tolerability of prophylactic (preventative) treatment with BOTOX® (onabotulinumtoxinA) compared to topiramate in adults with chronic migraine.

Eligibility Criteria

Inclusion

  • History of chronic migraine
  • More than 15 headache days in a 28 day period (headaches that last more than 4 hours and/or require treatment with prescription medication).

Exclusion

  • Taking opioid-containing products for acute headache treatment more than 8 days during a 28-day period
  • Previous treatment with botulinum toxin of any serotype for any reason
  • Previous treatment with topiramate
  • On a ketogenic diet (high in fat, low in carbohydrates)
  • History of acute myopia or increased intraocular pressure
  • Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis or any other significant disease that might interfere with neuromuscular function
  • Acupuncture, transcutaneous electrical stimulation (TENS), cranial traction, dental splints for headache, or injection of anesthetics/steroids in the 4 weeks prior to screening.

Key Trial Info

Start Date :

August 5 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2017

Estimated Enrollment :

282 Patients enrolled

Trial Details

Trial ID

NCT02191579

Start Date

August 5 2014

End Date

September 1 2017

Last Update

June 7 2018

Active Locations (32)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (32 locations)

1

St Joseph's Hospital Barrow Neurology Clinics

Phoenix, Arizona, United States, 85013

2

North County Neurology Associates

Encinitas, California, United States, 92024

3

California Headache and Balance Center

Fresno, California, United States, 93723

4

Newport Beach Clinical Research Associates, Inc.

Newport Beach, California, United States, 92663